Thrombolysis 3 to 4.5 Hours After Ischemic Stroke: An Update
Gregory J. del Zoppo
Abstract
Gregory J. del Zoppo
Abstract
This study is an updated assessment of data from the ongoing Safe Implementation of Treatments in Stroke–International Stroke Thrombolysis Registry (SITS-ISTR), a partially manufacturer-funded, prospective, multicenter, international database of patients with ischemic stroke treated with alteplase between December 2002 and February 2010. Some changes in treatment may have occurred during this period, as it spanned the publication (in October 2008) of the European Cooperative Acute Stroke Study (ECASS) III, in which alteplase given 3.0 to 4.5 hours after ischemic stroke onset produced similar outcomes to treatment within 3.0 hours, with no additional hemorrhage risk. The principal …
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This study is an updated assessment of data from the ongoing Safe Implementation of Treatments in Stroke–International Stroke Thrombolysis Registry (SITS-ISTR), a partially manufacturer-funded, prospective, multicenter, international database of patients with ischemic stroke treated with alteplase between December 2002 and February 2010. Some changes in treatment may have occurred during this period, as it spanned the publication (in October 2008) of the European Cooperative Acute Stroke Study (ECASS) III, in which alteplase given 3.0 to 4.5 hours after ischemic stroke onset produced similar outcomes to treatment within 3.0 hours, with no additional hemorrhage risk. The principal …
Key concepts: Medicine, Thrombolysis, Stroke (engine), Ischemic stroke, Emergency medicine, Acute stroke, Internal medicine, Tissue plasminogen activator